The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry

Brachytherapy

Volumn 6, Issue 3, 2007, Pages 173-179

  Neill, Mischel ^a   Studer, Gabrielle ^a   Le, Lisa ^a   McLean, Michael ^a   Yeung, Ivan ^a   Pond, Greg ^a   Crook, Juanita M ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Prostat brachytherapy; Urethral dosimetry; Urinary morbidity

Indexed keywords

IODINE 125;

ADULT; ARTICLE; BRACHYTHERAPY; CATHETERIZATION; DOSIMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROSTATE DISEASE; RADIATION DOSE; SCORING SYSTEM; TRANSRECTAL ULTRASONOGRAPHY; ULTRAVIOLET RADIATION; URETHRA; URINARY TRACT DISEASE;

BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENDOSONOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MORBIDITY; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RECTUM; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; URETHRA; URETHRAL STRICTURE; URINATION DISORDERS;

EID: 34547515067     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2007.03.003     Document Type: Article

References (22)

1. Sherenz T., Wallner K., Wang H., et al. Long-term urinary function after transperineal brachytherapy for patients with large prostate glands. Int J Radiat Oncol Biol Phys 51 (2001) 1241-1245
2. Locke J., Ellis W., Wallner K., et al. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study. Int J Radiat Oncol Biol Phys 52 (2002) 712-719
3. 125I prostate brachytherapy. Brachytherapy 1 (2002) 131-137
4. Merrick G.S., Butler W.M., Wallner K.E., et al. Long-term urinary quality of life following permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 56 (2003) 454-461
5. Crook J., McLean M., Catton C., et al. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys 52 (2002) 453-460
6. Terk M.D., Stock R.G., and Stone N.N. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 160 (1998) 1379-1382
7. Wallner K., Roy J., and Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 32 (1995) 465-471
8. Taussky D., Austen L., Toi A., et al. Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion. Int J Radiat Oncol Biol Phys 62 (2005) 974-980
9. Nath R., Anderson L.L., Luxton G., et al. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys 22 (1995) 209-234
10. Merrick G.S., Butler W.M., Dorsey A.T., et al. The dependence of prostate postimplant dosimetric quality on CT volume determination. Int J Radiat Oncol Biol Phys 44 (1999) 1111-1117
11. Zisman A., Leibovici D., Kleinmann J., et al. The impact of prostate biopsy on patient well-being: A prospective study of voiding impairment. J Urol 166 (2001) 2242-2246
12. Borboroglu P.G., Comer S.W., Riffenburgh R.H., et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 163 (2000) 158-160
13. Gelblum D.Y., Potters L., Ashley R., et al. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys 45 (1999) 59-67
14. Kang S.K., Chou R.H., Dodge R.K., et al. Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method. Int J Radiat Oncol Biol Phys 50 (2001) 937-945
15. Merrick G.S., Butler W.M., Galbreath R.W., et al. Relationships between the transition zone index of the prostate gland and urinary morbidity after brachytherapy. Urology 57 (2001) 905-908
16. Yue N., Dicker A.P., Nath R., et al. The impact of edema on planning 125I and 103Pd prostate implants. Med Phys 26 (1999) 763-767
17. Shearer R.J., Davies J.H., Gelister J.S., et al. Hormonal cytoreduction and radiotherapy for carcinoma of the prostate. Br J Urol 62 (1992) 521-524
18. Forman J.D., Kumar R., Haas G., et al. Neoadjuvant hormonal down-sizing of localized carcinoma of the prostate: Effects on the volume of normal tissue irradiation. Cancer Invest 13 (1995) 8-15
19. Hinerman-Mulroy A., Merrick G.S., Butler W.M., et al. Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy. Int J Radiat Oncol Biol Phys 59 (2004) 1367-1382
20. Andersson K.E. Storage and voiding symptoms: Physiological aspects. Urology 62 (2003) S3-S10
21. Lee H.K., D'Souza W.D., Yamal J.M., et al. Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 57 (2003) 355-361
22. Allen Z.A., Merrick G.S., Butler W.M., et al. Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity. Int J Radiat Oncol Biol Phys 62 (2005) 981-987